KCM
DXCM icon

Kingdon Capital Management’s DexCom DXCM Stock Holding History

Kingdon Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,400
Closed -$4.89M – 84
2023
Q3 		$4.89M Buy
+52,400
New +$5.91M 0.56% 52
2022
Q3 		– Sell
-74,400
Closed -$5.54M – 73
2022
Q2 		$5.54M Buy
+74,400
New +$6.79M 0.94% 37

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kingdon Capital Management's DXCM Position: Q4 2023 in Review

Kingdon Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 52,400 shares — an estimated $4.89M sold.

Kingdon Capital Management first reported a position in DXCM in Q2 2022 and held it in 2 quarters. The position peaked at $5.54M in Q2 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Kingdon Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Kingdon Capital Management sold 52,400 DexCom shares in Q4 2023, an estimated $4.89M.
  • Kingdon Capital Management first reported a position in DexCom in Q2 2022 and held it in 2 quarters.
  • Kingdon Capital Management's DexCom position peaked at $5.54M in Q2 2022.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Kingdon Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.